Valuation: Bayer AG

Market Cap 43.21B 48.38B 39.91B 36.17B 67.67B 4,593B 68.79B 480B 190B 2,406B 182B 178B 7,587B P/E 2026 *
18.6x
P/E 2027 * 13.9x
Enterprise Value 72.88B 81.61B 67.33B 61.01B 114B 7,747B 116B 810B 321B 4,059B 306B 300B 12,797B EV / Sales 2026 *
1.59x
EV / Sales 2027 * 1.48x
Free-Float
99.99%
Yield 2026 *
0.32%
Yield 2027 * 1.27%
1 day-0.52%
1 week-1.08%
Current month-8.28%
1 month-10.81%
3 months-4.81%
6 months+9.84%
Current year+18.83%
1 week 43.08
Extreme 43.08
44.83
1 month 42.56
Extreme 42.56
51
Current year 32.96
Extreme 32.96
53.92
1 year 25.78
Extreme 25.78
53.92
3 years 18.38
Extreme 18.378
53.92
5 years 18.38
Extreme 18.378
67.99
10 years 18.38
Extreme 18.378
123.9
Manager TitleAgeSince
Chief Executive Officer 60 31/05/2023
Director of Finance/CFO 57 31/05/2026
Chief Tech/Sci/R&D Officer 59 31/01/2021
Director TitleAgeSince
Director/Board Member 56 31/03/2012
Director/Board Member 61 31/03/2017
Chairman 68 27/04/2020
Date Insider Type Main position Quantity % Market Cap. Importance
18/03/26 Buy

Director

1,900 0.0002%
18/03/26 Buy

Executive/Senior Manager

13,000 0.0013%
18/03/26 Buy

Director

1,500 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
-0.52%-1.08%+59.46%+7.31% 48.38B
-2.54%+1.31%+55.10%+120.84% 1,135B
-1.42%+3.23%+37.07%+74.26% 636B
+0.16%+0.08%+25.14%+97.36% 505B
-0.31%+3.09%+43.92%+64.55% 378B
-1.34%-0.47%+66.63%+40.56% 358B
-0.68%+2.65%+22.46%+51.48% 295B
-1.20%+3.04%+2.62%+26.97% 266B
-1.79%+1.57%+49.97%+60.87% 237B
-0.73%-0.10%+29.24%+101.19% 193B
Average -0.65%+1.84%+39.16%+64.54% 405.27B
Weighted average by Cap. -0.26%+2.62%+41.21%+81.24%

Financials

2026 *2027 *
Net sales 45.87B 51.37B 42.37B 38.4B 71.84B 4,876B 73.03B 510B 202B 2,555B 193B 189B 8,054B 47.05B 52.69B 43.47B 39.39B 73.69B 5,002B 74.91B 523B 207B 2,621B 198B 194B 8,262B
Net income 2.3B 2.57B 2.12B 1.92B 3.6B 244B 3.66B 25.53B 10.11B 128B 9.65B 9.45B 403B 3.02B 3.39B 2.79B 2.53B 4.74B 322B 4.82B 33.62B 13.31B 168B 12.71B 12.44B 531B
Net Debt 29.67B 33.23B 27.41B 24.84B 46.47B 3,154B 47.24B 330B 131B 1,653B 125B 122B 5,210B 26.44B 29.6B 24.42B 22.13B 41.4B 2,810B 42.09B 294B 116B 1,472B 111B 109B 4,642B
Projected Income Statement - Annual - Bayer AG
Logo Bayer AG
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
87,830
Date Price Change Volume
23/10/26 €43.98 -0.52% 1,183,777
22/10/26 €44.21 -0.94% 1,609,760
21/10/26 €44.63 +2.64% 2,315,327
20/10/26 €43.48 +0.18% 1,427,483
19/10/26 €43.40 -2.38% 1,852,493
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Bayer AG
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
43.98EUR
Average target price
58.22EUR
Spread / Average Target
+32.38%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Bayer AG
  1. Stock Market
  2. Stocks
  3. BAYN Stock